Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
BMJ Quality & Safety
|
December 25, 2015
Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study
Bruce L Lambert, Scott R Schroeder, William L Galanter
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 4, 2003
Immediate free recall of drug names: effects of similarity and availability
Bruce L Lambert, Ken-Yu Chang, Swu-Jane Lin
Health Services Research
|
November 29, 2016
Changes in Physician Practice Patterns after Implementation of a Communication-and-Resolution Program
Lorens A Helmchen, Bruce L Lambert, Timothy B McDonald
American Journal of Pharmaceutical Education
|
August 23, 2013
The 4-year evolution of a social and behavioral pharmacy course
Joseph A Zorek, Bruce L Lambert, Nicholas G Popovich
JAMA
|
August 5, 2010
Antiepileptic medications and the risk of suicide
Robert D Gibbons, Bruce L Lambert, J John Mann
Journal of Clinical Psychopharmacology
|
January 12, 2005
Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia
Bruce L Lambert, Ken-Yu Chang, Eskinder Tafesse, et al.
Journal of Health Communication
|
October 8, 2013
Nurse overestimation of patients' health literacy
Carolyn Dickens, Bruce L Lambert, Terese Cromwell, et al.
Journal of Biopharmaceutical Statistics
|
May 27, 2015
Detection and prediction limits for identifying highly confusable drug names from experimental data
Bruce L Lambert, Runa Bhaumik, Weihan Zhao, et al.
Journal of the American Medical Informatics Association : JAMIA
|
February 12, 2013
Indication-based prescribing prevents wrong-patient medication errors in computerized provider order entry (CPOE)
William Galanter, Suzanne Falck, Matthew Burns, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 30, 2014
A case study in generic drug use: should there be risk adjustment in incentive payments for the use of generic medications?
Surrey M Walton, Christine Rash, Bruce L Lambert, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
BMJ Quality & Safety
|
December 25, 2015
Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study
Bruce L Lambert, Scott R Schroeder, William L Galanter
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 4, 2003
Immediate free recall of drug names: effects of similarity and availability
Bruce L Lambert, Ken-Yu Chang, Swu-Jane Lin
Health Services Research
|
November 29, 2016
Changes in Physician Practice Patterns after Implementation of a Communication-and-Resolution Program
Lorens A Helmchen, Bruce L Lambert, Timothy B McDonald
American Journal of Pharmaceutical Education
|
August 23, 2013
The 4-year evolution of a social and behavioral pharmacy course
Joseph A Zorek, Bruce L Lambert, Nicholas G Popovich
JAMA
|
August 5, 2010
Antiepileptic medications and the risk of suicide
Robert D Gibbons, Bruce L Lambert, J John Mann
Journal of Clinical Psychopharmacology
|
January 12, 2005
Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia
Bruce L Lambert, Ken-Yu Chang, Eskinder Tafesse, et al.
Journal of Health Communication
|
October 8, 2013
Nurse overestimation of patients' health literacy
Carolyn Dickens, Bruce L Lambert, Terese Cromwell, et al.
Journal of Biopharmaceutical Statistics
|
May 27, 2015
Detection and prediction limits for identifying highly confusable drug names from experimental data
Bruce L Lambert, Runa Bhaumik, Weihan Zhao, et al.
Journal of the American Medical Informatics Association : JAMIA
|
February 12, 2013
Indication-based prescribing prevents wrong-patient medication errors in computerized provider order entry (CPOE)
William Galanter, Suzanne Falck, Matthew Burns, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 30, 2014
A case study in generic drug use: should there be risk adjustment in incentive payments for the use of generic medications?
Surrey M Walton, Christine Rash, Bruce L Lambert, et al.
Page
of 8